{"disease":{"id":"bone-metastases","name":"bone metastases"},"drugs":{"marketed":[{"drug_id":"radium-223","indication_name":"Castration-Resistant Prostate Cancer, Bone Metastases","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Radium-223","generic_name":"radium-223","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Bone cells","drug_class":"Radiopharmaceutical","quality_score":50,"revenue":"400","mechanism":""},{"drug_id":"pamidronate","indication_name":"Osteolytic Bone Metastases of Breast Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pamidronate","company_name":"US Department of Veterans Affairs","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Hypoxanthine-guanine phosphoribosyltransferase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"zoledronic-acid","indication_name":"Bone Metastases from Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zometa","generic_name":"ZOLEDRONIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"zoledronic acid","quality_score":80,"revenue":null,"mechanism":"Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity."},{"drug_id":"zoledronic-acid","indication_name":"Bone Metastases of Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zometa","generic_name":"ZOLEDRONIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"zoledronic acid","quality_score":80,"revenue":null,"mechanism":"Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity."},{"drug_id":"zometa","indication_name":"Bone Metastases of Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zometa","company_name":"University of Arkansas","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zoledronate","indication_name":"Bone Metastases of Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zoledronate","company_name":"Children's Hospital Medical Center, Cincinnati","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pamidronic-acid","indication_name":"Osteolytic Bone Metastases of Breast Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aredia","generic_name":"PAMIDRONIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"Bisphosphonate","quality_score":36,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06544668","title":"A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06335251","title":"Radiotherapy Treatments for Neoplasms of the Limbs","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT03244020","title":"LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2868,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT00321464","title":"A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2049,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00321620","title":"Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1904,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00330759","title":"Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1779,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01345019","title":"Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1718,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03924609","title":"Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT02051218","title":"Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1380,"lead_sponsor_name":"Swiss Cancer Institute","has_results":false},{"nct_id":"NCT06221072","title":"A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1360,"lead_sponsor_name":"Shanghai JMT-Bio Inc.","has_results":false},{"nct_id":"NCT06153576","title":"The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures","phase":"","overall_status":"COMPLETED","enrollment_count":1120,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03689439","title":"Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT00699751","title":"A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":921,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06713941","title":"Management of Bone Metastases","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":900,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04859569","title":"Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":850,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT06367491","title":"National Database of Bone Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","has_results":false},{"nct_id":"NCT01231347","title":"QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"NantCell, Inc.","has_results":true},{"nct_id":"NCT04812509","title":"Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":708,"lead_sponsor_name":"Mabwell (Shanghai) Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT04550949","title":"To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02410044","title":"Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"iOMEDICO AG","has_results":false},{"nct_id":"NCT06703944","title":"Risk Model for Metastasis Detection of Neuroblastoma","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06392217","title":"clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04720391","title":"Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT03597984","title":"Reduction of Pain Symptoms With Stereotactic Radiotherapy on Bone Metastases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":330,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04063254","title":"A Prospective Randomized Trial of High Dose Versus Standard Dose Stereotactic Radiotherapy for Pain Control in Patients With Bone Metastases","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":302,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03223597","title":"Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT01248585","title":"Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":298,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":true},{"nct_id":"NCT04630522","title":"Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":295,"lead_sponsor_name":"Shanghai JMT-Bio Inc.","has_results":false},{"nct_id":"NCT05614518","title":"Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"HTA Co., Ltd.","has_results":false},{"nct_id":"NCT06805396","title":"Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: a Randomized Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":246,"lead_sponsor_name":"Roxanne Gal","has_results":false},{"nct_id":"NCT06065449","title":"A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04307914","title":"Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":216,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT03814811","title":"Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05825456","title":"Metastatic Pathologic Fractures, Short Term Results","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ankara University","has_results":false},{"nct_id":"NCT05730972","title":"TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":188,"lead_sponsor_name":"The Third Affiliated hospital of Zhejiang Chinese Medical University","has_results":false},{"nct_id":"NCT07196995","title":"Validation of Whole Body PET/CT Foundation Model","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Shanghai 6th People's Hospital","has_results":false},{"nct_id":"NCT03143322","title":"Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":168,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT02163226","title":"A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT05406063","title":"Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases","phase":"NA","overall_status":"RECRUITING","enrollment_count":162,"lead_sponsor_name":"Kantonsspital Winterthur KSW","has_results":false},{"nct_id":"NCT03453905","title":"Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Metastases: a Randomized Controlled Study.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":162,"lead_sponsor_name":"Tel-Aviv Sourasky Medical Center","has_results":false},{"nct_id":"NCT04568291","title":"CTC in Lung Caner Patients With Bone Metastases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Shanghai 6th People's Hospital","has_results":false},{"nct_id":"NCT04159376","title":"Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Tel-Aviv Sourasky Medical Center","has_results":false},{"nct_id":"NCT07171996","title":"Research on the Optimization of Treatment for Spinal Metastases With Radioactive Particle Implantation Using TPS and Mechanical Dual Simulation","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Li Min","has_results":false},{"nct_id":"NCT04157166","title":"Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT \"VERITON-CT ™\" Camera","phase":"NA","overall_status":"UNKNOWN","enrollment_count":146,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT01419717","title":"Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03336983","title":"Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","has_results":false},{"nct_id":"NCT07112989","title":"Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":125,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT04995614","title":"Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04947280","title":"Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03188926","title":"Surgical Treatment of Long Bone Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}